Guangdong Newdarin Biotechnology Co., Ltd. is a R&D-driven high-tech biopharmaceutical enterprise, dedicated to the R&D and commercial production of original new drugs and their core intermediates, high-end APIs and their core intermediates. The company complies with the quality management requirements of the US FDA and the European Union EUGMP, and practices the international standard drug quality management norms and strict drug production management system to ensure product quality.
Newdarin Biotech actively implements the talent strategy and has high-level management talents and technical teams in the biopharmaceutical industry, thus ensuring the company's tenacious vitality and excellent competitiveness in the biopharmaceutical field.
Based on the principles of high efficiency, environmental protection and high quality, Newdarin Biotech is based in China, looks at the world, sets itself the benchmark of the industry, and builds a world-class biomedical supplier!
more >
Year of Establishment:
2019
Total Assets(USD):
Total Number of Staff:
100-500
Main Competitive Advantages:
International Approvals/Standards,Experienced R&D Staff,Delivery Term,Buyers' Specifications Accepted,Small Orders Accepted,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
OEM,ODM
Annual Turnover(USD):
Main Sales Markets:
North America,Central/South America,Western Europe,Australasia,Asia
Other Competitive Advantages:
Patents and Copyrights:
Audited Supplier
Pharma Sources Insight JANUARY 2024
